Microenvironment Determinants of Brain Metastasis

被引:0
作者
Chenyu Zhang
Dihua Yu
机构
[1] The University of Texas M.D. Anderson Cancer Center,Department of Molecular and Cellular Oncology
来源
Cell & Bioscience | / 1卷
关键词
Brain Metastasis; Breast Cancer Brain Metastasis; Melanoma Brain Metastasis; Treat Brain Metastasis; Tumor Cell Extravasation;
D O I
暂无
中图分类号
学科分类号
摘要
Metastasis accounts for 90% of cancer-related mortality. Brain metastases generally present during the late stages in the natural history of cancer progression. Recent advances in cancer treatment and management have resulted in better control of systemic disease metastatic to organs other than the brain and improved patient survival. However, patients who experience recurrent disease manifest an increasing number of brain metastases, which are usually refractory to therapies. To meet the new challenges of controlling brain metastasis, the research community has been tackling the problem with novel experimental models and research tools, which have led to an improved understanding of brain metastasis. The time-tested "seed-and-soil" hypothesis of metastasis indicates that successful outgrowth of deadly metastatic tumors depends on permissible interactions between the metastatic cancer cells and the site-specific microenvironment in the host organs. Consistently, recent studies indicate that the brain, the major component of the central nervous system, has unique physiological features that can determine the outcome of metastatic tumor growth. The current review summarizes recent discoveries on these tumor-brain interactions, and the potential clinical implications these novel findings could have for the better treatment of patients with brain metastasis.
引用
收藏
相关论文
共 217 条
[1]  
Patchell RA(2003)The management of brain metastases Cancer Treat Rev 29 533-540
[2]  
Johnson JD(1996)Demographics of brain metastasis Neurosurg Clin N Am 7 337-344
[3]  
Young B(2007)A patient perspective on brain metastases in breast cancer Clin Cancer Res 13 1623-1624
[4]  
Mayer M(2005)Increased risk of brain metastases in patients with HER-2/neu-positive breast carcinoma Cancer 103 442-443
[5]  
Altaha R(2006)Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer Breast 15 219-225
[6]  
Crowell E(2006)Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab Acta Oncol 45 196-201
[7]  
Hobbs G(2010)Brain metastases Semin Neurol 30 217-235
[8]  
Higa G(2003)The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited Nat Rev Cancer 3 453-458
[9]  
Abraham J(2005)Rodent models of brain metastasis in melanoma Melanoma Res 15 325-356
[10]  
Stemmler HJ(2001)A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro J Bone Miner Res 16 1486-1495